Pulmonary Fibrosis: The GP's role in early detection and management

While Pulmonary Fibrosis (PF) is considered rare in Australia, disease burden is significant and prevalence is increasing year by year. Detection and diagnosis can be complex, particularly as signs and symptoms of PF mirror numerous other respiratory and cardiac conditions. Early and accurate diagnosis and referral is a critical step in optimising patient outcomes in this progressive disease. While there is no cure for PF, there are various evidence-based treatment options and management strategies to help slow or stop progression and manage symptoms.

To mark Pulmonary Fibrosis Awareness Month this September, Lung Foundation Australia is proud to present this virtual learning event focussed on earlier detection, diagnosis and management of PF in primary care.

Ask our expert panel your questions at registration, or live during the Q&A session.

Learning outcomes:

• Outline the disease burden of Pulmonary Fibrosis in Australia.
• Discuss evidence-based practice to support earlier detection and diagnosis of Pulmonary Fibrosis.
• Identify support pathways and resources for best-practice management of Pulmonary Fibrosis in Australia.